(Q44098879)

29 November 2017

title

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging (English)

1 reference

29 November 2017

0 references

1 reference

Keith A Horvath

1

1 reference

29 November 2017

John Doukas

2

1 reference

29 November 2017

Chia-Yang J Lu

3

1 reference

29 November 2017

Noam Belkind

4

1 reference

29 November 2017

Rodney Greene

5

1 reference

29 November 2017

Glenn F Pierce

6

1 reference

29 November 2017

David A Fullerton

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

The Annals of Thoracic Surgery

29 November 2017

published in

1 reference

29 November 2017

volume

74

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

481-6; discussion 487

1 reference

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Mechanisms of angiogenesis and arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Time course of arteriogenesis following femoral artery occlusion in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Left ventricular functional improvement after transmyocardial laser revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Clinical applications of angiogenic growth factors and their inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Adenoviruses as gene-delivery vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

Thoracic Surgery Directors Association Award. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903736-0

10.1016/S0003-4975(02)03736-0

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference